Contact Information
Company Information
Company
Avalyn Pharma Inc.
Total Funding
273700000.0
Technologies
Outlook
Microsoft Office 365
Google Cloud Hosting
Salesforce
Nginx
Mobile Friendly
Typekit
reCAPTCHA
Google Tag Manager
Bootstrap Framework
Vimeo
WordPress.org
Keywords
biotechnology research
inhaled therapies
pulmonary fibrosis
interstitial lung diseases
pipeline
clinical trials
inhaled formulations
effective medicines
rare respiratory diseases
ap01
ap02
ap03
inhaled pirfenidone
inhaled nintedanib
fixed dose combination
systemic exposure
efficacy
safety profile
drug delivery
chronic disease
fibrotic diseases
treatment options
patient compliance
clinical development
biotech
biopharmaceuticals
novel therapies
drug side effects
pulmonary hypertension
lung function
health-related quality of life
aerosol delivery
targeted therapies
patient-centered
drug formulation
tolerability
randomized controlled trials
drug approvals
medical research
investor relations
biopharma
therapeutic advancements
disease progression
active substances
anti-inflammatory drugs
small molecule inhibitors
caregiver support
respiratory medicine
biomarker studies
dose optimization
molecular therapy
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans